文献速递儿童神经与发育行为儿童内分泌与遗传代谢

母亲自身免疫性疾病与儿童注意缺陷多动障碍的关联

Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children.
PubMed 文献 · JAMA Pediatr · 2021-03-01

基于澳大利亚新南威尔士州2000至2010年出生的足月单胎儿童队列,将12 610名暴露于母亲自身免疫性疾病的儿童按1:4倾向评分匹配至50 440名未暴露儿童,共63 050人。队列分析显示,母亲患任何自身免疫性疾病与子代ADHD风险升高相关(HR 1.30;95%CI 1.15-1.46),1型糖尿病、银屑病、风湿热或风湿性心脏炎也分别与ADHD相关。系统综述与荟萃分析纳入5项研究,同样支持母亲自身免疫性疾病、1型糖尿病、甲状腺功能亢进和银屑病与ADHD的关联。

要点

  • 母亲任何自身免疫性疾病与子代ADHD风险升高相关,校正后HR为1.30(95%CI 1.15-1.46)。
  • 母亲1型糖尿病与子代ADHD关联最强,队列中HR为2.23(95%CI 1.66-3.00)。
  • 荟萃分析中母亲1型糖尿病、甲亢、银屑病均与ADHD相关,提示可能存在共同遗传易感性或母体免疫激活机制。

核心结论

  • 母亲自身免疫性疾病与子代ADHD风险升高相关,可能反映自身免疫病与ADHD共享遗传易感性或母体免疫激活在神经发育障碍中的作用。

研究设计与样本

  • 基于澳大利亚新南威尔士州2000年7月1日至2010年12月31日出生、随访至2014年底的足月单胎儿童队列,并进行系统综述与荟萃分析。
  • 队列将12 610名暴露于母亲自身免疫性疾病的儿童按1:4倾向评分匹配至50 440名未暴露儿童,总队列63 050人。

主要发现

  • 队列中母亲任何自身免疫性疾病与子代ADHD相关(HR 1.30;95%CI 1.15-1.46)。
  • 队列中母亲1型糖尿病(HR 2.23;95%CI 1.66-3.00)、银屑病(HR 1.66;95%CI 1.02-2.70)、风湿热或风湿性心脏炎(HR 1.75;95%CI 1.06-2.89)与子代ADHD相关。
  • 荟萃分析中母亲任何自身免疫性疾病(2项研究:HR 1.20;95%CI 1.03-1.38)、1型糖尿病(4项研究:HR 1.53;95%CI 1.27-1.85)、甲状腺功能亢进(3项研究:HR 1.15;95%CI 1.06-1.26)、银屑病(2项研究:HR 1.31;95%CI 1.10-1.56)与ADHD相关。

关键数值与推荐

  • ADHD判定标准为存在兴奋剂治疗授权或处方,或住院记录中有ADHD诊断;3岁前出现首次ADHD事件的儿童被排除。

临床怎么用

  • 对母亲患有自身免疫性疾病(尤其1型糖尿病、银屑病、风湿热或风湿性心脏炎、甲亢)的儿童,可关注ADHD相关行为表现并适时评估。

局限性

  • 原文指出需进一步研究疾病活动度、修饰因素和用药情况,以更好理解该关联的机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Maternal autoimmune disease has been associated with increased risk of neurodevelopmental disorders in offspring, but few studies have assessed the association with attention-deficit/hyperactivity disorder (ADHD). OBJECTIVE: To examine the association between maternal autoimmune disease and ADHD within a population-based cohort and combine results in a subsequent systematic review and meta-analysis. DESIGN, SETTING, AND PARTICIPANTS: A cohort study was conducted of singleton children born at term gestation (37-41 weeks) in New South Wales, Australia, from July 1, 2000, to December 31, 2010, and followed up until the end of 2014; and a systematic review evaluated articles from the MEDLINE, Embase, and Web of Science databases to identify all studies published before November 20, 2019. A total of 12 610 children exposed to maternal autoimmune disease were propensity score matched (1:4) to 50 440 unexposed children, for a total cohort of 63 050. A child was considered to have ADHD if they had (1) an authorization or filled prescription for stimulant treatment for ADHD or (2) a hospital diagnosis of ADHD. Children linked to a first ADHD event before 3 years of age were excluded. Data were analyzed from January 13 to April 20, 2020. EXPOSURES: One or more maternal autoimmune diagnoses in linked hospital admission records between July 1, 2000, and December 31, 2012. Thirty-five conditions were considered together and individually. MAIN OUTCOMES AND MEASURES: The main outcome was child ADHD identified from stimulant authorization or prescription data and diagnoses in linked hospital admission records. Multivariable Cox regression was used to assess the association between maternal autoimmune disease and ADHD adjusted for child sex. Pooled hazard ratios (HRs) were calculated using random-effects meta-analysis with inverse-variance weights for each exposure reported by 2 or more studies. RESULTS: In the population-based cohort analysis, 831 718 singleton, term infants born to 831 718 mothers (mean [SD] age, 29.8 [5.6] years) were assessed. Of 12 767 infants (1.5%) who were linked to a maternal autoimmune diagnosis, 12 610 were propensity score matched to 50 440 control infants, for a total study cohort of 63 050 infants. In this cohort, any autoimmune disease was associated with ADHD in offspring (HR, 1.30; 95% CI 1.15-1.46), as was type 1 diabetes (HR, 2.23; 95% CI, 1.66-3.00), psoriasis (HR, 1.66; 95% CI, 1.02-2.70), and rheumatic fever or rheumatic carditis (HR, 1.75; 95% CI, 1.06-2.89). Five studies (including the present study) were included in the meta-analysis. Any autoimmune disease (2 studies: HR, 1.20; 95% CI, 1.03-1.38), type 1 diabetes (4 studies: HR, 1.53; 95% CI, 1.27-1.85), hyperthyroidism (3 studies: HR, 1.15; 95% CI, 1.06-1.26), and psoriasis (2 studies: HR, 1.31; 95% CI, 1.10-1.56) were associated with ADHD. CONCLUSIONS AND RELEVANCE: In this cohort study, maternal autoimmune diseases were associated with increased ADHD among children. These findings suggest possible shared genetic vulnerability between autoimmune disease and ADHD or a potential role for maternal immune activation in the expression of neurodevelopmental disorders in children. Future studies measuring disease activity, modifiers, and medication use are required to better understand the mechanisms underlying this association.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Nielsen TC, Nassar N, Shand AW, et al. Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children. JAMA Pediatr. 2021. PMID: 33464287. doi:10.1001/jamapediatrics.2020.5487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。